Aiping Zhou
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Pancreatic and Hepatic Oncology Research
- Gastroenterology top 10%
Papers in
-
- Gastric Cancer Management and Outcomes 20
- Renal cell carcinoma treatment 14
- Oncology 36
- Colorectal Cancer Treatments and Studies 17
- Cancer Immunotherapy and Biomarkers 9
- Co-authors
- Jiyan Liu (8 shared papers)Hong Luo (8 shared papers)Benkang Shi (5 shared papers)Jianming Ying (6 shared papers)Yongkun Sun (15 shared papers)Jinjing Ni (3 shared papers)Jinwan Wang (14 shared papers)Wen Zhang (15 shared papers)
- Journals
- Journal of Clinical Oncology (17 papers)Annals of Oncology (6 papers)BMC Cancer (2 papers)Clinical & Translational Oncology (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Aiping Zhou
76 papers receiving 983 citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Oncology 465
- Gastroenterology 60
- Pulmonary and Respiratory Medicine 290
- Surgery 349
- Infectious Diseases 123
Countries citing papers authored by Aiping Zhou
This map shows the geographic impact of Aiping Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aiping Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aiping Zhou more than expected).
Fields of papers citing papers by Aiping Zhou
This network shows the impact of papers produced by Aiping Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aiping Zhou. The network helps show where Aiping Zhou may publish in the future.
Co-authors
The 25 scholars most cited alongside Aiping Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Open-label, Multicenter, Phase II Study of RC48-ADC, a HER2-Targeting Antibody–Drug Conjugate, in Patients with Locally Advanced or Metastatic Urothelial Carcinoma Hit paper breakdown → | 2020 | 192 |
| 2 | 2019 | 80 | |
| 3 | 2013 | 76 | |
| 4 | 2020 | 75 | |
| 5 | 2021 | 41 | |
| 6 | 2023 | 38 | |
| 7 | 2017 | 32 | |
| 8 | 2015 | 26 | |
| 9 | 2022 | 24 | |
| 10 | 2020 | 22 | |
| 11 | 2018 | 21 | |
| 12 | 2011 | 20 | |
| 13 | 2022 | 19 | |
| 14 | 2012 | 19 | |
| 15 | 2011 | 19 | |
| 16 | 2020 | 17 | |
| 17 | 2018 | 15 | |
| 18 | 2013 | 14 | |
| 19 | 2020 | 13 | |
| 20 | 2016 | 12 |
About Aiping Zhou
Aiping Zhou is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Molecular Biology and Cancer Research, having authored 78 papers that have together received 996 indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (20 papers), Colorectal Cancer Treatments and Studies (17 papers), Renal cell carcinoma treatment (14 papers), Bladder and Urothelial Cancer Treatments (10 papers), Cancer Immunotherapy and Biomarkers (9 papers), Esophageal Cancer Research and Treatment (9 papers), Gastrointestinal Tumor Research and Treatment (8 papers) and Cancer Genomics and Diagnostics (7 papers). The work is most often cited by research in Oncology (465 citations), Gastroenterology (60 citations), Pulmonary and Respiratory Medicine (290 citations), Surgery (349 citations) and Infectious Diseases (123 citations). Aiping Zhou has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Jiyan Liu, Hong Luo, Benkang Shi, Jianming Ying, Yongkun Sun, Jinjing Ni, Jinwan Wang, Wen Zhang, Cheng Fu and Petros C. Karakousis. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, BMC Cancer, Clinical & Translational Oncology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.